GeneQuine Biotherapeutics to Present at Gene Therapy Conference 2014 (December 3-4, 2014, Brussels) [ 01 Dec 2014 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at Gene Therapy Conference, Europe’s only industry-focused gene therapy Event, on December 4th.

GeneQuine's CEO Dr. Kilian Guse and VP Dr. Stanislav Plutizki will present GeneQuine's development programs and technology and discuss synergies in the development of human and veterinary gene therapy drugs.